Kevin Mclaughlin, SVP, CFO & Treas at Acceleron Pharma, holds 1.75K shares in Vericel (Ticker: VCEL), holds 11.22K shares in Acceleron Pharma (Ticker: XLRN).

See the Hottest Stocks Based on Insider Trading >

Kevin Mclaughlin
Acceleron Pharma (XLRN)
SVP, CFO & Treas

Ranked #23,892 out of 78,624 Corporate Insiders

Profitable Transactions

4 out of 7 Profitable Transactions

Average Return

+4.90%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

96.77%

XLRN

3.23%

VCEL

A breakdown of Kevin Mclaughlin's holdings

See the Top Stocks by Insiders

Insider Roles

Acceleron Pharma
(XLRN)

SVP, CFO & Treas

Vericel
(VCEL)

Director

Roles that Kevin Mclaughlin holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Acceleron Pharma
(XLRN)

Rating:Informative Buy

Date:Jan 04, 2017 - Jan 04, 2018

Return:+56.10%

The most profitable trade made by Kevin Mclaughlin

See the Latest Stocks Traded by Insiders

Kevin Mclaughlin's Trading History

XLRN

Acceleron Pharma

Apr 10, 2020

SVP, CFO & Treas

Uninformative Sell

4.66M

$1.32M

VCEL

Vericel

May 01, 2020

Director

Uninformative Buy

―

$44.10K

List of latest transactions for each holding click on a transaction to see Kevin Mclaughlin's performance on stock

See All Insider Trading from Today

Kevin Mclaughlin insider profile FAQ

What is the percentage of profitable transactions made by Kevin Mclaughlin?

The percentage of profitable transactions made by Kevin Mclaughlin is 57%.

What is the average return per transaction made by Kevin Mclaughlin?

The average return per transaction made by Kevin Mclaughlin is 4.90%.

What stocks does Kevin Mclaughlin hold?

Kevin Mclaughlin holds: XLRN, VCEL stocks.

What was Kevin Mclaughlin’s latest transaction?

Kevin Mclaughlin latest transaction was an Uninformative Buy of ―.

What was Kevin Mclaughlin's most profitable transaction?

Kevin Mclaughlin’s most profitable transaction was an Informative Buy of XLRN stock on January 4, 2017. The return on the trade was 56.10%.

What is Kevin Mclaughlin's role in Acceleron Pharma?

Kevin Mclaughlin's role in Acceleron Pharma is SVP, CFO & Treas.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Kevin Mclaughlin Insider Profile

Kevin Mclaughlin Acceleron Pharma (XLRN)SVP, CFO & Treas